Skip to main content

1 Result(s)

within C. Tonert Remove this filter

and

  1. No Access

    Chapter and Conference Paper

    Prognostic Significance of Exposure to Intermediate-Dose Methotrexate in Children with Standard Risk ALL: The COALL 82/85 Experience

    Methotrexate is being widely used in doses ranging from 500 to 2 000 mg administered as prolonged infusion over 12–36 h followed by leucovorin rescue to consolidate remission of acute lymphoblastic leukemia [1...

    H. Jürgens, G. Janka, M. Ibrahim, C. Tonert, K. Winkler, U. Göbel in Acute Leukemias (1992)